New weight loss drug shows promise in early human trial
NCT ID NCT06640647
First seen Dec 16, 2025 · Last updated May 12, 2026 · Updated 17 times
Summary
This early-stage study tested a single dose of HDM1005 in 65 healthy adults to check its safety and how the body processes it. Researchers also looked at changes in weight and other health markers. The goal is to see if this drug could help with weight management in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY AND OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, China
Conditions
Explore the condition pages connected to this study.